HIMS stock rated an Outperform by TD Cowen


Hims & Hers Health Inc.’s recent filing unveils that its Chief Financial Officer Okupe Oluyemi unloaded Company’s shares for reported $46319.0 on Aug 21. In the deal valued at $6.92 per share,6,698 shares were sold. As a result of this transaction, Okupe Oluyemi now holds 125,016 shares worth roughly $ 0.85 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, O’Keefe Lynne Chou sold 45,748 shares, generating $327,098 in total proceeds. Upon selling the shares at $7.15, the Director now owns 0 shares.

Before that, Dudum Andrew sold 6,900 shares. Hims & Hers Health Inc. shares valued at $62,382 were divested by the Chief Executive Officer at a price of $9.04 per share. As a result of the transaction, Dudum Andrew now holds 0 shares, worth roughly $0.0.

TD Cowen initiated its Hims & Hers Health Inc. [HIMS] rating to an Outperform in a research note published on Friday, July 28, 2023; the price target was $11. PT values the company’s stock at a premium of 38.09 to its Friday closing price.

Price Performance Review of HIMS

On Friday, Hims & Hers Health Inc. [NYSE:HIMS] saw its stock jump 1.49% to $6.81. On the same session, the stock had its day’s lowest price of $6.595, but rose to a high of $6.865. Hims & Hers Health Inc. shares have risen nearly 6.24% since the year began. Nevertheless, the stocks have risen 9.31% over the past one year. While a 52-week high of $12.34 was reached on 05/08/23, a 52-week low of $4.01 was recorded on 01/06/23. SMA at 50 days reached $8.15, while 200 days put it at $8.54. A total of 1.6 million shares were traded, compared to the trading of 1.64 million shares in the previous session.

Levels Of Support And Resistance For HIMS Stock

The 24-hour chart illustrates a support level at 6.65, which if violated will result in even more drops to 6.49. On the upside, there is a resistance level at 6.92. A further resistance level may holdings at 7.03. The Relative Strength Index (RSI) on the 14-day chart is 33.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.22, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.98%. Stochastics %K at 5.96% indicates the stock is a buying.

How much short interest is there in Hims & Hers Health Inc.?

A steep rise in short interest was recorded in Hims & Hers Health Inc. stocks on Aug 14, 2023, dropping by -6.81 million shares to a total of 17.68 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 24.49 million shares. There was a decline of -38.52%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 11.30% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.76.

Hims & Hers Health Inc. [HIMS] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 13,347,513 shares, or roughly 6.64% of the outstanding HIMS shares. In other words, the investor’s shares have risen by 1,930,775 from its previous 13-F filing of 11416738.0. Additionally, BlackRock Fund Advisors increased 5.81% of its stake after which the total value it holdings stand at $72,979,077, while Marshall Wace LLP added 47.97% of its stake to hold $52.71 million in the firm. Over the last quarter, Samlyn Capital LLC purchased 3,111,834 shares of Hims & Hers Health Inc., while Millennium Management LLC bought 1,076,502 shares. At present, SSgA Funds Management, Inc. is holding 2,991,941 shares valued at $26.84 million. Chimera Capital Management LLC owned 2,395,793 shares of the company at the time of its most recent 13F filing, worth $21.49 million.

According to FactSet, Hims & Hers Health Inc.’s share price will average $12.30 in the next year, based on opinions of analysts polled by the firm. This is up nearly 71.39 percent from its previous closing price of $6.71. Analysts expect Hims & Hers Health Inc. stock to reach the higher price of $18.00, while the lowest price estimate is $8.00. However, 10 analysts have rated HIMS stock as an Overweight in their predictions for 2023.


Please enter your comment!
Please enter your name here